You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Capecitabine

Showing 51 - 75 of 2,332
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in Kansas City, Rochester, Saint Louis (ATI-2231, Capecitabine, Denosumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • Kansas City, Kansas
  • +2 more
Mar 16, 2023

Cholangiocarcinoma, Intrahepatic Trial in Shanghai (Capecitabine, PD-1 Antibody(Tislelizumab))

Recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Capecitabine
  • PD-1 Antibody（Tislelizumab）
  • Shanghai, China
    Lulu@Huashan.Org.Cn
Aug 16, 2022

Metastatic Colorectal Cancer Trial in Beijing (fruquintinib plus capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • fruquintinib plus capecitabine
  • Beijing, China
    National Center/Cancer Hospital, China Academy of Medical Scienc
Aug 17, 2022

Metastatic Nasopharyngeal Carcinoma Trial (Capecitabine plus toripalimab)

Not yet recruiting
  • Metastatic Nasopharyngeal Carcinoma
  • Capecitabine plus toripalimab
  • (no location specified)
Jul 30, 2022

Unresectable Metastatic Colorectal Cancer Trial in Beijing (fruquintinib plus capecitabine)

Recruiting
  • Unresectable Metastatic Colorectal Cancer
  • fruquintinib plus capecitabine
  • Beijing, China
    Beijing Friendship Hospital
Aug 17, 2022

Metastatic Breast Cancer, Advanced Breast Cancer, HER2-positive Breast Cancer Trial (Margetuximab, Tucatinib, Capecitabine)

Withdrawn
  • Metastatic Breast Cancer
  • +2 more
  • (no location specified)
Jul 6, 2022

Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract

Recruiting
  • Biliary Tract Neoplasms
  • +3 more
  • Shanghai, China
    Huashan hospital
Aug 16, 2022

Breast Cancer Trial in Chicago (Cyclophosphamide, Methotrexate, Capecitabine)

Recruiting
  • Breast Cancer
  • Chicago, Illinois
    University of Illinois
Oct 18, 2023

Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,

Recruiting
  • Biliary Tract Cancer (CCA)
  • +4 more
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Jun 23, 2022

Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Shanghai (Pyrotinib Plus Capecitabine combined with brain

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Pyrotinib Plus Capecitabine combined with brain radiotherapy
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 14, 2023

Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • (no location specified)
Feb 10, 2022

Adenocarcinoma of Small Intestine, Appendix Carcinoma, Metastatic Trial in Guangzhou (Surufatinib)

Recruiting
  • Adenocarcinoma of Small Intestine
  • +2 more
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Jul 22, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (Sintilimab, Capecitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 5, 2022

Breast Cancer Trial (Capecitabine and Neratinib.)

Not yet recruiting
  • Breast Cancer
  • Capecitabine and Neratinib.
  • (no location specified)
Jul 8, 2022

Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (Taxane plus Intermittent Capecitabine, Utidelone

Not yet recruiting
  • Breast Neoplasms
  • Locally Advanced or Metastatic Breast Cancer
  • Taxane plus Intermittent Capecitabine
  • +3 more
  • Guangzhou, Guangdong, China
    Shusen Wang
Dec 27, 2021

Nasopharyngeal Carcinoma Trial in China (Endostatin and Capecitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Endostatin and Capecitabine
  • Hangzhou, Zhejiang, China
  • +6 more
Aug 21, 2022

Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)

Recruiting
  • Colonic Neoplasms
  • +2 more
  • Nanning, Guangxi, China
    The First Affiliated Hospital of Guangxi Medical University
Nov 9, 2023

Pseudomyxoma Peritonei Trial in Milano (Capecitabine)

Recruiting
  • Pseudomyxoma Peritonei
  • Capecitabine
  • Milano, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 4, 2022

Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)

Active, not recruiting
  • Colo-rectal Cancer
  • Metastatic Cancer
  • Besançon, France
  • +2 more
Jan 24, 2023

RECTAL CANCER Trial in Faenza (Capecitabine, Radiotherapy, Durvalumab)

Recruiting
  • RECTAL CANCER
  • Capecitabine
  • +2 more
  • Faenza, Italy
    Ospedale Degli Infermi Uo Oncologia
Jul 19, 2022

Advanced Colorectal Carcinoma Trial in Beijing (OH2, Capecitabine, Bevacizumab)

Not yet recruiting
  • Advanced Colorectal Carcinoma
  • OH2
  • +2 more
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Jan 28, 2023

Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine

Completed
  • Breast Cancer
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Jun 30, 2022

    Radiotherapy, PD-1 Inhibitor, Capecitabine Trial in Zhuhai (SBRT radiotherapy + Conventionally fractionated radiotherapy, PD-1

    Recruiting
    • Radiotherapy
    • +3 more
    • SBRT radiotherapy + Conventionally fractionated radiotherapy
    • +2 more
    • Zhuhai, Guangdong, China
      Fifth Affilliated Hospital of Sun Yat-sen University
    Apr 13, 2022

    Hematopoietic and Lymphoid System Tumor, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial (BET

    Not yet recruiting
    • Hematopoietic and Lymphoid System Neoplasm
    • +5 more
    • BET Bromodomain Inhibitor ZEN-3694
    • +6 more
    • (no location specified)
    Apr 6, 2023

    A Nationwide Multicenter, Ambispective Real-world Study of

    Recruiting
    • Breast Cancer
      • Zhengzhou, Henan, China
        Henan cancer hospital
      Sep 15, 2022